AscellaHealth Releases Q4 2024 Specialty & Rare Pipeline Digest™

PipelineDigest_2024Q4_Article_MAR-152-010325.1

Featuring Key Specialty Drug, Biosimilar, Cell and Gene Therapy Approvals

Format

PNG

Source

AscellaHealth, LLC

Téléchargements